| Condition | Inheritance | Mutation mechanism | Gene | Protein |
| Osteopetrosis, severe neonatal or infantile forms | AR | Loss of function | TCIRG1 | Subunit of V-ATPase pump |
| RANKL | Receptor Activator for Nuclear Factor κB Ligand | |||
| OSTM1 | Osteopetrosis associated transmembrane protein | |||
| CLCN7 | Chloride channel | |||
| RANK | Receptor Activator for Nuclear Factor κB | |||
| Osteopetrosis, intermediate form | AR | Loss of function | CLCN7 | Chloride channel |
| PLEKHM1 | Pleckstrin homology domain containing family M, member 1 | |||
| Osteopetrosis with renal tubular acidosis | AR | Loss of function | CAII | Carbonic anhydrase II |
| Osteopetrosis, late-onset form (Albers-Schönberg disease) | AD | Dominant negative | CLCN7 | Chloride channel |
| Osteopetrosis with ectodermal dysplasia and immune defect (OLEDAID) | XL | Loss of function | IKBKG (NEMO) | Inhibitor of kappa light polypeptide gene enhancer, kinase of |
| Leukocyte adhesion deficiency syndrome (LAD-III) and osteopetrosis | AR | Loss of function | Kindlin-3 | Kindlin-3 |
| CalDAG-GEF1 | Calcium and diacylglycerol-regulated guanine nucleotide exchange factor 1 | |||
| Pyknodysostosis | AR | Loss of function | CTSK | Cathepsin K |
| Osteopoikilosis | AD | Loss of function | LEMD3 | LEM domain-containing 3 |
| Melorheostosis with osteopoikilosis | AD | Loss of function | LEMD3 | LEM domain-containing 3 |
| Dysosteosclerosis | AR |
|
|
|
| Osteomesopyknosis | AD |
|
|
|
| Osteopathia striata congenita with cranial stenosis | XL | Loss of function | WTX | Wilms tumour gene on the X chromosome |
| Osteosclerosis, Stanescu type | AD |
|
|
|